Does low-molecular-weight heparin improve live birth rates in pregnant women with thrombophilic disorders? A systematic review

Singapore Medical Journal

Volumn 53, Issue 10, 2012, Pages 659-663

  Tan, Wei Keat ^a   Lim, Shau Khng ^a   Tan, Lay Kok ^a   Bauptista, Dianne ^b  

^a SINGAPORE GENERAL HOSPITAL   (Singapore)

^b SINGAPORE CLINICAL RESEARCH INSTITUTE   (Singapore)

Author keywords

Enoxaparin; Live birth; Low molecular weight heparin; Pregnancy; Thrombophilia

Indexed keywords

ACETYLSALICYLIC ACID; LOW MOLECULAR WEIGHT HEPARIN; PLACEBO;

ARTICLE; ECHOGRAPHY; EMBRYO TRANSFER; FERTILIZATION IN VITRO; HUMAN; LIVE BIRTH; OUTCOME ASSESSMENT; PREGNANCY OUTCOME; PREGNANT WOMAN; RANDOMIZED CONTROLLED TRIAL (TOPIC); SPONTANEOUS ABORTION; SYSTEMATIC REVIEW; THROMBOPHILIA;

FEMALE; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS, HEMATOLOGIC; PREGNANCY OUTCOME; THROMBOPHILIA; TREATMENT OUTCOME;

EID: 84869991022     PISSN: 00375675     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. David M Luesley, Philip N Baker, Obstetrics and gynaecology, an evidencebased test for MRCOG, 2nd ed. London: Edward Arnold (Publishers) Ltd., 2010.
2. Pabinger I, Vormittag R. Thrombophilia and pregnancy outcomes. J Thromb Haemost 2005; 3:1603-1610.
3. Robertson L, Wu O, Langhorne P, et al. Thrombophilia in pregnancy: a systematic review. Br J Haematol 2006; 132:171-196.
4. Rodger M.A, Paidas M, McLintock C, et al. Inherited thrombophilia and pregnancy complications revisited. Obstet Gynecol 2008; 112:320-324.
5. Clark P, Walker I.D, Langhorne P, et al. SPIN (Scottish Pregnancy Intervention) study: a multicenter, randomized controlled trial of low-molecular-weight heparin and low-dose aspirin in women with recurrent miscarriage. Blood 2010; 115:4162-4167.
6. Huw T O Davies, Iain K Crombie. What is? Series, 2nd ed. What is a systematic review? [online]. Available at: www.medicine.ox.ac.uk/bandolier/painres/download/.../syst-review. Accessed October 8, 2012.
7. Julian P.T Higgins and Douglas G Altman. Assessing risk of bias in included studies. Chapter 8, The Cochrane Book Series [online]. Available at: www.cochrane.org/handbook/chapter-8-assessing-risk-bias-included-studies. Accessed October 8, 2012.
8. Fletcher J. What is heterogeneity and is it important? BMJ 2007; 334:94-96.
9. Gates S, Brocklehurst P, Ayers S, et al. Thromboprophylaxis and pregnancy: two randomized controlled pilot trials that used low-molecular-weight heparin. Am J Obstet Gynecol 2004; 191:1296-1303.
10. Fawzy M, Shokeir T, El-Tatongy M, et al. Treatment options and pregnancy outcome in women with idiopathic recurrent miscarriage: a randomized placebo-controlled study. Arch Gynecol Obstet 2008; 278:33-38.
11. Fouda U.M, Sayed A.M, Ramadan D.I, Fouda I.M. Efficacy and safety of two doses of low molecular weight heparin (enoxaparin) in pregnant women with a history of recurrent abortion secondary to antiphospholipid syndrome. J Obstet Gynaecol 2010; 30:842-846.
12. Visser J, Ulander V.M, Helmerhorst F.M, et al. Thromboprophylaxis for recurrent miscarriage in women with or without thrombophilia. HABENOX: a randomised multicentre trial. Thromb Haemost 2011; 105:295-301.
13. Gris J.C, Mercier E, Quéré I, et al. Low-molecular-weight heparin versus lowdose aspirin in women with one fetal loss and a constitutional thrombophilic disorder. Blood 2004; 103:3695-3699.
14. Qublan H, Amarin Z, Dabbas M, et al. Low-molecular-weight heparin in the treatment of recurrent IVF-ET failure and thrombophilia: a prospective randomized placebo-controlled trial. Hum Fertil (Camb) 2008; 11:246-253.
15. Laskin C.A, Spitzer K.A, Clark C.A, et al. Low molecular weight heparin and aspirin for recurrent pregnancy loss: results from the randomized, controlled HepASA Trial. J Rheumatol 2009; 36:279-287.
16. Mak A, Cheung M.W, Cheak A.A, Ho R.C. Combination of heparin and aspirin is superior to aspirin alone in enhancing live births in patients with recurrent pregnancy loss and positive anti-phospholipid antibodies: a meta-analysis of randomized controlled trials and meta-regression. Rheumatology (Oxford) 2010; 49:281-288.
17. RCOG guideline 2003, Guideline No. 17. The investigation and treatment of couples with recurrent miscarriage. London: RCOG, 2003.
18. Ruiz-Irastorza G, Khamashta M.A, Hughes G.R. Treatment of pregnancy loss in Hughes syndrome: a critical update. Autoimmun Rev 2002; 1:298-304.
19. Kutteh W.H. Antiphospholipid antibody-associated recurrent pregnancy loss: treatment with heaprin and low dose aspirin is superior to low dose aspirin alone. Am J Obstet Gynecol 1996; 174:1584-1589.
20. Rai R, Cohen H, Dave M, Regan L. Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies). BMJ 1997; 314:253-257.
21. Sanson B.J, Friederich P.W, Simioni P, et al. The risk of abortion and stillbirth in antithrombin-, protein C-, and protein S-deficient women. Thromb Haemost 1996; 75:387-388.
22. Geva E, Amit A, Lerner-Geva L, et al. Autoimmune disorders: another possible cause for in-vitro fertilization and embryo transfer failure. Hum Reprod 1995; 10:2560-2563.
23. Grandone, E., Colaizzo, D., Lo Bue, A et al. Inherited thrombophilia and in vitro fertilization implantation failure. Fertil Steril 2001; 76:201-202.
24. Azem F, Many A, Ben Ami I, et al. Increased rates of thrombophilia in women with repeated IVF failure. Hum Reprod 2004; 19:368-370.
25. Kujovich J.L. Thrombophilia and pregnancy complications. Am J Obstet Gynecol 2004; 191:412-424.
26. Chamley L.W, Duncalf A.M, Mitchell M.D, Johnson P.M. Action of anticardiolipin and antibodies to beta2-glycoprotein-I on trophoblast proliferation as a mechanism for fetal death. Lancet 1998; 352:1037-1038.
27. Mak I.Y, Brosens J.J, Christian M, et al. Regulated expression of signal transducer and activator of transcription, Stat5, and its enhancement of PRL expression in human endometrial stromal cells in vitro. J Clin Endocrinol Metab 2002; 87:2581-2588.
28. Quenby S, Mountfield S, Cartwright J.E, et al. Antiphospholipid antibodies prevent extravillous trophoblast differentiation. Fertil Steril 2005; 83:691-698.
29. Kwak-Kim J.Y, Chung-Bang H.S, Ng S.C, et al. Increased T helper 1 cytokine responses by circulating T cells are present in women with recurrent pregnancy losses and in infertile women with multiple implantation failures after IVF. Hum Reprod 2003; 18:767-773.
30. Geva E, Amit A, Lerner-Geva L, et al. Prednisone and aspirin improve pregnancy rate in patients with reproductive failure and autoimmune antibodies: a prospective study. Am J Reprod Immunol 2000; 43:36-40.
31. Fiedler K, Würfel W. Effectivity of heparin in assisted reproduction. Eur J Med Res 2004; 9:207-214.
32. Greer I.A, Nelson-Piercy C. Low-molecular-weight heparins for thromboprophylaxis and treatment of venous thromboembolism in pregnancy: a systematic review of safety and efficacy. Blood 2005; 106:401-407.
33. Di Nisio M, Peters L, Middeldorp S. Anticoagulants for the treatment of recurrent pregnancy loss in women without antiphospholipid syndrome. Cochrane Database Syst Rev 2005:CD004734.
34. Kovalevsky G, Gracia C.R, Berlin J.A, Sammel M.D, Barnhart K.T. Evaluation of the association between hereditary thrombophilias and recurrent pregnancy loss: a meta-analysis. Arch Intern Med 2004; 164:558-563.